Team

Nia Therapeutics is a team of visionary scientists, engineers and medical device experts dedicated to improving human memory using safe, secure neurotechnology.

• Dan Rizzuto, PhD

  Founder, CEO

  Dr. Rizzuto developed Nia's core technology at the University of Pennsylvania as part of the DARPA Restoring Active Memory Project.  He completed his doctorate in the neuroscience of human memory at Brandeis University, his postdoctoral training in brain-machine interfaces at Caltech.
• Daniel Utin

  CTO

  Daniel is an expert in developing secure, scalable, high-volume software systems. Before Nia, he worked at MIT Lincoln Lab developing cybersecurity technologies, where he won the R&D 100 award. He previously co-founded two software companies, both acquired.
• Mike Kahana, PhD

  Founder & Chairman of the Scientific Advisory Board

  Mike is the Edmund and Louise Kahn Term Professor of Psychology at the University of Pennsylvania and the co-inventor of Nia’s core technology. Mike received the Troland Award and the Warren Medal for his discoveries in human memory and neuroscience.
• Chris Ho

  Principal Software Developer

  Chris is a full-stack software engineer with over 20 years of experience involving user interfaces, communication, databases, security, operations, and regulatory compliance. Chris was previously the director of technology at MD Connect.
• Andrew Smiles

  Implantable Systems Engineer

  Andrew is a systems design engineer specialized in creating biological to digital interfaces. He previously developed bidirectional neural interfaces for amputees during his work at the University of Waterloo and at the Centre for Bionics and Pain Research.

Advisors

• Bob Gross, MD PhD

  Professor, Dept. of Neurosurgery at Emory University

• Tim Denison, PhD

  Royal Academy Chair in Emerging Technology at Oxford University

• Ramon Diaz-Arrastia, MD PhD

  Professor of Neurology and Director of TBI Clinical Research, University of Pennsylvania

• Geoff Aguirre, MD PhD

  Associate Professor of Neurology at University of Pennsylvania

• Bob Greenberg, MD PhD

  Executive Chairman at The Alfred Mann Foundation